ライフサイエンスコーパス: chlorhexidine

1 were analyzed (164 soap and water versus 161 chlorhexidine).

2 ents (9.6%) met the definition of allergy to chlorhexidine.

3 athogens than did clinical concentrations of chlorhexidine.

4 actions, 9.6% were diagnosed with allergy to chlorhexidine.

5 acter baylyi rendered it more susceptible to chlorhexidine.

6 t and specific interactions between AceI and chlorhexidine.

7 stance and transport, was still able to bind chlorhexidine.

8 le to mediate the energy-dependent efflux of chlorhexidine.

9 ed in significant increases in resistance to chlorhexidine.

10 rred in 7 patients, were mild and related to chlorhexidine.

11 matitis rate was 1.1% with and 0.29% without chlorhexidine.

12 to compare antiplaque efficacy in vivo with chlorhexidine.

13 reased after oral rinsing with antibacterial chlorhexidine.

14 cally active: clotrimazole, flunarizine, and chlorhexidine.

15 etracycline, minocycline, metronidazole, and chlorhexidine.

16 was inhibited by protease inhibitors or 0.2% chlorhexidine.

17 ggested a lack of resistance to mupirocin or chlorhexidine.

18 se the ocular safety and efficacy of aqueous chlorhexidine.

19 aily bathing of critically ill patients with chlorhexidine.

20 nal specialists who exclusively used aqueous chlorhexidine 0.05% or 0.1% for prophylaxis of infective

21 d panel; many failed to screen all cases for chlorhexidine 19/44 (43%) or latex 21/44 (48%)], staffin

22 contaminated disks were burnished with 0.12% chlorhexidine, 20% citric acid, 24% EDTA/1.5% NaOCl, or

23 4934 infants were assigned to 4.0% chlorhexidine, 5107 to cleansing with soap and water, an

24 he following: NMBA (35%), antibiotics (46%), chlorhexidine (8%), patent blue dye (8%) and others (8%)

25 arison of their relative susceptibilities to chlorhexidine, a drug widely used to treat Acanthamoeba

26 in overall SSI rate between IPA (18.7%) and chlorhexidine-alcohol (15.9%) was 2.8% (P = 0.30).

27 were enrolled; 572 patients were assigned to chlorhexidine-alcohol and 575 to iodine-alcohol.

28 omparing iodine povacrylex-alcohol (IPA) and chlorhexidine-alcohol for elective, clean-contaminated c

29 The use of chlorhexidine-alcohol for preoperative skin antisepsis r

30 olled trial, we evaluated whether the use of chlorhexidine-alcohol for preoperative skin antisepsis w

31 cial surgical-site infection was 3.0% in the chlorhexidine-alcohol group and 4.9% in the iodine-alcoh

32 A total of 849 subjects (409 in the chlorhexidine-alcohol group and 440 in the povidone-iodi

33 n was diagnosed in 23 patients (4.0%) in the chlorhexidine-alcohol group and in 42 (7.3%) in the iodi

34 ite infection was significantly lower in the chlorhexidine-alcohol group than in the povidone-iodine

35 esized that preoperative skin cleansing with chlorhexidine-alcohol is more protective against infecti

36 erative cleansing of the patient's skin with chlorhexidine-alcohol is superior to cleansing with povi

37 ean delivery to skin preparation with either chlorhexidine-alcohol or iodine-alcohol.

38 to preoperative skin preparation with either chlorhexidine-alcohol scrub or povidone-iodine scrub and

39 Chlorhexidine-alcohol was significantly more protective

40 he intent to treat analysis (396 IPA and 392 chlorhexidine-alcohol).

41 ity for overall SSI prevention compared with chlorhexidine-alcohol.

42 aims were to estimate (i) the prevalence of chlorhexidine allergy in perioperative allergy and (ii)

43 Chlorhexidine allergy was post hoc defined as a relevant

44 Using our definition of chlorhexidine allergy, the highest combined estimated se

45 ity and sensitivity for diagnostic tests for chlorhexidine allergy.

46 There was no mortality benefit with chlorhexidine although the sample size was small.

47 te was 2.86 per 1000 patient-days during the chlorhexidine and 2.90 per 1000 patient-days during the

48 nktonic S. sanguinis was 112.8 microg/ml for chlorhexidine and 9.0 microg/ml for chlorine dioxide.

49 Reduced susceptibility to chlorhexidine and carriage of qacA or qacB were rare amo

50 at plaque formation was inhibited/reduced by chlorhexidine and honey rinses.

51 Chlorhexidine and latex are not part of routine testing

52 n, and decolonisation of MRSA carriers) with chlorhexidine and mupirocin, and universal decolonisatio

53 decolonization, targeted decolonization with chlorhexidine and mupirocin, or universal decolonization

54 no screening, all patients decolonised) with chlorhexidine and mupirocin.

55 2 (11.9%) patients had died in the mupirocin/chlorhexidine and placebo groups, respectively.

56 most common skin preparation wipes (alcohol, chlorhexidine and povidone iodine) and found that during

57 ditional prevention measures (oral care with chlorhexidine and selective oral decontamination).

58 e further discovered the target of action of chlorhexidine and show that it is a selective inhibitor

59 ated with either 5-fluorouracil (n = 480) or chlorhexidine and silver sulfadiazine (n = 480).

60 bacteria, and Candida were cultured from the chlorhexidine and silver sulfadiazine central venous cat

61 ated with 5-fluorouracil were noninferior to chlorhexidine and silver sulfadiazine coated central ven

62 of the 5-fluorouracil group and 0.9% of the chlorhexidine and silver sulfadiazine group.

63 roup, whereas two episodes were noted in the chlorhexidine and silver sulfadiazine group.

64 ernative to catheters externally coated with chlorhexidine and silver sulfadiazine when used in criti

65 d with 5-fluorouracil with those coated with chlorhexidine and silver sulfadiazine.

66 standard catheter or a catheter coated with chlorhexidine and silver sulfadiazine.

67 t formulations, such as an antiseptic cream (chlorhexidine) and a nicotine-containing skin patch, is

68 metronidazole, a group of other antibiotics, chlorhexidine, and a group of antimicrobials.

69 t that boric acid could be an alternative to chlorhexidine, and it might be more favorable because bo

70 oral bacteria and compare the same with 0.2% chlorhexidine; and 2) to compare antiplaque efficacy in

71 Use of chlorhexidine antisepsis seems to attenuate the effect o

72 Evidence from Asia suggests that chlorhexidine application to the neonatal umbilical cord

73 rolled trials evaluating efficacy of topical chlorhexidine applied to the oropharynx vs. placebo or s

74 0.0%) infants in the chlorhexidine group had chlorhexidine applied within 24 h of birth.

75 Perioperative allergic reactions to chlorhexidine are often severe and easily overlooked.

76 Chlorhexidine at stock concentration achieved about a 2

77 Chlorhexidine-based preparations are significantly more

78 We conclude that daily chlorhexidine bathing among ICU patients may reduce the

79 onization-treatment of all ICU patients with chlorhexidine bathing and nasal mupirocin-used a prerele

80 Chlorhexidine bathing did not change rates of infection-

81 Compared with soap and water bathing, chlorhexidine bathing every other day decreased the risk

82 Compared with soap and water, chlorhexidine bathing every other day decreased the risk

83 pathogen nonspecific (global), such as daily chlorhexidine bathing of all patients in the ICU.

84 During the chlorhexidine bathing period, 55 infections occurred: 4

85 on was 5.10 cases per 1000 patient-days with chlorhexidine bathing versus 6.60 cases per 1000 patient

86 ns was 4.78 cases per 1000 patient-days with chlorhexidine bathing versus 6.60 cases per 1000 patient

87 tudy sought to determine if the use of daily chlorhexidine bathing would decrease the incidence of co

88 n, 2) chlorhexidine oral hygiene program, 3) chlorhexidine bathing, 4) catheter-associated bloodstrea

89 control practices (ie, active surveillance, chlorhexidine bathing, decolonization for MRSA, and hydr

90 03), the equivalent of a 23% lower rate with chlorhexidine bathing.

91 mia (p = 0.02) following the introduction of chlorhexidine bathing.

92 high level of compliance to hand hygiene and chlorhexidine bathings, screening and isolation of carri

93 unty, California, we evaluated the impact of chlorhexidine baths and mupirocin on all ICU admissions

94 ation of patients in the ICU with once a day chlorhexidine baths and short-course nasal mupirocin cou

95 rbidity and risk can be reduced with topical chlorhexidine, behavioral or other factors associated wi

96 ation measures, including once-weekly use of chlorhexidine body wash, did not prevent overall SSTI or

97 xin plus tobramycin and nasal mupirocin plus chlorhexidine body wash.

98 twice-daily intranasal mupirocin, and daily chlorhexidine body washes.

99 nasal carriers with mupirocin together with chlorhexidine body washing reduces the incidence of S. a

100 n interrupted time series study of universal chlorhexidine body-washing combined with hand hygiene im

101 Median proportions of patients receiving chlorhexidine body-washing increased from 0% to 100% at

102 Improved hand hygiene plus unit-wide chlorhexidine body-washing reduced acquisition of antimi

103 ed with blood culture kits containing either chlorhexidine (CH) or iodine tincture (IT) for skin anti

104 s: standard (S), enhanced standard (ES), and chlorhexidine (CHG).

105 t 3 and 6 months were retreated with renewed chlorhexidine chip application.

106 scaling and root planing plus application of chlorhexidine chips (test).

107 djunctive effect of subgingival placement of chlorhexidine chips after scaling and root planing.

108 ng and root planing followed by placement of chlorhexidine chips secured by cyanoacrylate at test sit

109 s, the systemic use of azithromycin (AZ) and chlorhexidine (CHX) as adjuvants to non-surgical periodo

110 sites releasing antibacterial agents such as chlorhexidine (CHX) have shown biofilm-inhibitory effica

111 this study is to determine the influence of chlorhexidine (CHX) intracanal medicament on the clinica

112 ) group II, TRP mouthwash; and 3) group III, chlorhexidine (CHX) mouthwash.

113 bstantivity of a single mouthrinse with 0.2% chlorhexidine (CHX) on saliva and on undisturbed de novo

114 olution (10(9) beads/mL) and, second, a 0.2% chlorhexidine (CHX) or 0.085% cetylpyridinium chloride (

115 available mouthwashes that contained either chlorhexidine (CHX) or essential oils (EO) as the active

116 t was suggested that periodontal therapy and chlorhexidine (CHX) rinse could affect nitrite levels, l

117 ecause standard adjuvant antiseptics, namely chlorhexidine (CHX), prove damaging for osteoblasts.

118 : povidone-iodine (PovI; 0.05%, 1%, and 5%), chlorhexidine (CHX; 0.2% and 1%), and sodium hypochlorit

119 Protocol included chlorhexidine cleansing of the perineum and proximal 6 i

120 Severe omphalitis in chlorhexidine clusters was reduced by 75% (incidence rat

121 c defined as a relevant clinical reaction to chlorhexidine combined with two or more positive tests.

122 Daily bathing with a chlorhexidine-containing solution.

123 eductions previously reported in south Asia, chlorhexidine cord applications did not significantly re

124 Chlorhexidine cord applications do not seem to provide c

125 r patients bathed with soap and water versus chlorhexidine, counts of incident hospital-acquired infe

126 in the units: chlorhexidine "scrub-the-hub," chlorhexidine daily baths, and daily nursing rounds aime

127 ventions, especially after implementation of chlorhexidine daily baths.

128 Transport assays using [(14)C]-chlorhexidine determined that AceI was able to mediate t

129 ions at screening) to test the efficacy of a chlorhexidine diacetate 10% weight per volume (w/v) dent

130 system can be effectively controlled by the chlorhexidine diacetate content and pH.

131 fer, which was attributed to the increase of chlorhexidine diacetate solubility at lower pH.

132 iller, and the ratios of calcium fluoride to chlorhexidine diacetate were 8/2, 5/5, and 2/8.

133 In this pragmatic trial, daily bathing with chlorhexidine did not reduce the incidence of health car

134 Systemic antibiotics and topical chlorhexidine did not reduce the percentage of invaded e

135 onic antifungal drugs such as miconazole and chlorhexidine digluconate (CG) through ionic interaction

136 ence rate, 80% [12 of 15 isolates]) than for chlorhexidine digluconate (median growth grade, 1.0; kil

137 whether polyhexamethylene biguanide, 0.02%, chlorhexidine digluconate, 0.02%, hexamidine diisethioon

138 -mouth SRP using 0.9% sodium chloride, 0.12% chlorhexidine digluconate, or 7.5% povidone-iodine for s

139 ensive local antiseptic interventions with a chlorhexidine disc and hypochlorite solution reduce bact

140 Antisepsis drain care included (1) a chlorhexidine disc at the drain exit site and (2) irriga

141 The combination of erythritol and chlorhexidine displayed stronger antimicrobial and antib

142 hours or more in 12 French ICUs, we compared chlorhexidine dressings, highly adhesive dressings, and

143 With chlorhexidine dressings, the major-CRI rate was 67% lowe

144 ata are consistent with AceI being an active chlorhexidine efflux protein and the founding member of

145 Patients were randomized to bathing with 2% chlorhexidine every other day alternating with soap and

146 lts were comparable with those observed with chlorhexidine + F (positive control).

147 nts were randomly assigned to either 4% free chlorhexidine for cord care or to dry cord care using a

148 Greater use of chlorhexidine for disease prevention warrants surveillan

149 To assess the efficacy of topical chlorhexidine for prevention of ventilator-associated pn

150 Our findings do not support the use of chlorhexidine for reduction of neonatal mortality in thi

151 dy tested the hypothesis that the release of chlorhexidine from a urethane dimethacrylate and triethy

152 Different chemicals (i.e., chlorhexidine, galardin, and benzalkonium chloride) or c

153 e, consisting of head-of-bed elevation, oral chlorhexidine gel, sedation holds, and a weaning protoco

154 A large randomized trial demonstrated that chlorhexidine-gel-impregnated dressings decreased the CR

155 by repetitive intraperitoneal injections of chlorhexidine gluconate (CG) in mice with type I pro-col

156 ution of peritoneal MCs to myofibroblasts in chlorhexidine gluconate (CG)-induced fibrosis compared w

157 e collected and tested for susceptibility to chlorhexidine gluconate (CHG) by microtiter dilution; mu

158 ctive was to assess whether daily bathing in chlorhexidine gluconate (CHG) compared with standard bat

159 very of multispecies oral biofilms following chlorhexidine gluconate (CHX) and CHX with surface modif

160 Patients rinsed with 0.12% chlorhexidine gluconate after debridement, and twice dai

161 as treated conservatively with topical 0.12% chlorhexidine gluconate application.

162 ze antiseptic skin surface concentrations of chlorhexidine gluconate applied during preoperative show

163 s; geographic and personnel cohorting; daily chlorhexidine gluconate baths; dedicating equipment to b

164 The mean (SD) composite chlorhexidine gluconate concentrations were significantl

165 ion have assessed the safety and efficacy of chlorhexidine gluconate for cutaneous antisepsis and sil

166 Although chlorhexidine gluconate is a known cause of contact derm

167 the use of an ultrasonic unit, and that 0.2% chlorhexidine gluconate is more effective than herbal mo

168 The chlorhexidine gluconate rinse had the lowest MICs compar

169 surface (16.5 microg/cm2) concentrations of chlorhexidine gluconate that are sufficient to inhibit o

170 preoperative decontamination protocol using chlorhexidine gluconate washcloths and intranasal antise

171 Skin surface concentrations of chlorhexidine gluconate were analyzed using colorimetric

172 Volunteers used 118 mL of chlorhexidine gluconate, 4%, for each shower.

173 ower regimen that includes 118 mL of aqueous chlorhexidine gluconate, 4%, per shower; a minimum of 2

174 r administering the preadmission shower with chlorhexidine gluconate, 4%, resulting in maximal, persi

175 The volunteers were randomized to 2 chlorhexidine gluconate, 4%, showering groups (2 vs 3 sh

176 Preadmission showers using chlorhexidine gluconate, 4%.

177 is by delineating a precise dose (volume) of chlorhexidine gluconate, 4%; duration (number of showers

178 le preprocedural mouthrinses containing 0.2% chlorhexidine gluconate, an herbal mouthwash, and water

179 nd C) of eight patients each to receive 0.2% chlorhexidine gluconate, herbal mouthwash, and water, re

180 nhibitory effects of three test agents, 0.2% chlorhexidine gluconate, honey mouthwash, and saline, ag

181 and placed in 3 ml of sterile saline, 0.12% chlorhexidine gluconate, or 0.1% phosphate-buffered chlo

182 The safety and efficacy of chlorhexidine gluconate, silver alginate, and antibiotic

183 lesions resolved with discontinuation of the chlorhexidine gluconate-containing dressings, local woun

184 Chlorhexidine gluconate-impregnated dressings have becom

185 e phenotypic range of this adverse effect of chlorhexidine gluconate-impregnated dressings in critica

186 titis is an under-recognized complication of chlorhexidine gluconate-impregnated dressings.

187 f erosive irritant contact dermatitis due to chlorhexidine gluconate-impregnated transparent dressing

188 ion antiseptic skin cleansing protocol using chlorhexidine gluconate.

189 ingle rooms; bathing all patients daily with chlorhexidine gluconate; and healthcare-worker education

190 No difference was observed between the chlorhexidine- gluconate-impregnated sponge group and th

191 ily for up to 5 days and to bathe daily with chlorhexidine-gluconate (CHG) for up to 5 days before th

192 r (standard group), a standard catheter plus chlorhexidine-gluconate-impregnated sponge (chlorhexidin

193 chlorhexidine-gluconate-impregnated sponge (chlorhexidine-gluconate-impregnated sponge group), or an

194 ients, 156 in the standard-group, 150 in the chlorhexidine-gluconate-impregnated sponge group, and 15

195 (15.4%) standard catheters, 21 (14%) in the chlorhexidine-gluconate-impregnated sponge group, and 25

196 e (5.8%) standard catheters, six (4%) in the chlorhexidine-gluconate-impregnated sponge group, and se

197 lity was significantly reduced by 34% in the chlorhexidine group (0.66 [0.46-0.95]).

198 Mortality rate in the chlorhexidine group (10.5 deaths per 1000 livebirths) wa

199 rence in neonatal mortality rate between the chlorhexidine group (15.2 deaths per 1000 livebirths) an

200 Neonatal mortality was 24% lower in the chlorhexidine group (relative risk 0.76 [95% CI 0.55-1.0

201 births, 18 450 (99.7%) newborn babies in the chlorhexidine group and 19 308 (99.8%) newborn babies in

202 16 660 (90.0%) infants in the chlorhexidine group had chlorhexidine applied within 24

203 17 468 (96.9%) of 18 015 neonates in the chlorhexidine group were available for complete follow-u

204 For babies allocated to the chlorhexidine group, mothers or caretakers were advised

205 definitions was reduced significantly in the chlorhexidine group.

206 VRE-colonized patients bathed with chlorhexidine had a lower risk of developing VRE bactere

207 Chlorhexidine has comparable effectiveness and is safer,

208 ed materials that release either fluoride or chlorhexidine have been formulated for inhibiting caries

209 eriodontitis (e.g., scaling/root planing and chlorhexidine) have limited efficacy since they fail to

210 Chlorhexidine-impregnated and strongly adherent dressing

211 olonization was also markedly reduced in the chlorhexidine-impregnated dressing group (random effects

212 Our analysis shows that a chlorhexidine-impregnated dressing is beneficial in prev

213 Use of a chlorhexidine-impregnated dressing resulted in a reduced

214 lar and femoral was suppressed by the use of chlorhexidine-impregnated dressings.

215 catheter-related infections and the costs of chlorhexidine-impregnated sponge and contact dermatitis

216 ssing cost $9.08 (146 observations) and each chlorhexidine-impregnated sponge cost $9.73.

217 atients, 28,931 catheter days) showed that a chlorhexidine-impregnated sponge decreased the incidence

218 ge use saved $197 per patient with the 3-day chlorhexidine-impregnated sponge dressing change strateg

219 Chlorhexidine-impregnated sponge for arterial and centra

220 Chlorhexidine-impregnated sponge use remained cost savin

221 incidence of 1.4 per thousand catheter days, chlorhexidine-impregnated sponge use saved $197 per pati

222 Here, we assessed the cost benefits of chlorhexidine-impregnated sponge use.

223 ce of multiresistant Gram-negative bacteria, chlorhexidine-impregnated sponges and Oligon catheters a

224 to evaluate the effect of daily bathing with chlorhexidine-impregnated washcloths on the acquisition

225 ed to bathe patients either with no-rinse 2% chlorhexidine-impregnated washcloths or with nonantimicr

226 Daily bathing with chlorhexidine-impregnated washcloths significantly reduc

227 washcloths (P=0.007), a 28% lower rate with chlorhexidine-impregnated washcloths.

228 The most effective antiseptic is 0.5% chlorhexidine in 80% ethanol, which is generally accepte

229 e hypothesized that the ratio of fluoride to chlorhexidine incorporated into a resin, and the pH of t

230 ps: 1) SRP + saline irrigation (C); 2) SRP + chlorhexidine irrigation (CHX); and 3) SRP + boric acid

231 ogic parameters and compare this method with chlorhexidine irrigation and SRP alone in patients with

232 Our analysis showed that topical chlorhexidine is beneficial in preventing VAP; the benef

233 new formulation consisting of erythritol and chlorhexidine is compared with the standard glycine powd

234 broad-spectrum, topical antimicrobial agent chlorhexidine is widely performed and may reduce health

235 Chlorhexidine is widely used as an antiseptic or disinfe

236 Chlorhexidine may compromise the biocompatibility of tit

237 suggest that daily bathing of patients with chlorhexidine may prevent hospital-acquired bloodstream

238 tion drainage endotracheal tubes, oral care, chlorhexidine mouth care, and daily spontaneous awakenin

239 with BRONJ were using antibiotics (48%) or a chlorhexidine mouthrinse (84%) at enrollment.

240 ygiene measures and were advised to use 0.2% chlorhexidine mouthwash for 1 week before being allocate

241 nical therapy and its association with 0.12% chlorhexidine mouthwash reduced peri-implant mucositis.

242 36 911 newborn babies were enrolled into the chlorhexidine (n=18 015) and dry cord care study (n=18 8

243 density and the antimicrobial mechanisms for chlorhexidine, nano-silver, quaternary ammonium methacry

244 of these findings that early antisepsis with chlorhexidine of the umbilical cord reduces local cord i

245 f a synergistic effect with the bisguanidine chlorhexidine on cell membrane disruption has been obser

246 is needed to determine the impact of topical chlorhexidine on mortality.

247 s with disposable cloths impregnated with 2% chlorhexidine or nonantimicrobial cloths as a control.

248 rogram with refresher education campaign, 2) chlorhexidine oral hygiene program, 3) chlorhexidine bat

249 257) received scaling and root planing plus chlorhexidine oral rinse at baseline and supportive peri

250 cluding manual tooth/gum brushing plus 0.12% chlorhexidine oral rinse, twice per day, plus upright po

251 nd in the saline-treated group compared with chlorhexidine (P = 0.03).

252 were similar (18.9% soap and water vs 18.6% chlorhexidine; p = 0.95).

253 and air polished with glycine or erythritol-chlorhexidine powders.

254 pedic, 61 vascular, and 56 other), mupirocin/chlorhexidine reduced 1-year mortality: 11 of 365 (3.0%)

255 harynx and the gastric tube plus a mupirocin/chlorhexidine regimen in intubated patients and standard

256 reater loss of organic components and higher chlorhexidine release rates.

257 e of fluoride salt substantially reduced the chlorhexidine release, while the presence of a specific

258 d acidic residue, although unable to mediate chlorhexidine resistance and transport, was still able t

259 ii, to chlorhexidine to identify the primary chlorhexidine resistance elements.

260 e isolates, with no evidence of mupirocin or chlorhexidine resistance.

261 Topical chlorhexidine resulted in a reduced incidence of VAP (re

262 Group differences in antibiotics and chlorhexidine rinse usage may have masked differences in

263 t of oral hygiene, scaling and root planing, chlorhexidine rinses, and periodontal maintenance.

264 membranes, soft tissue grafts, post-surgical chlorhexidine rinses, systemic antibiotics, and dressing

265 outh root planing, systemic antibiotics, and chlorhexidine rinses.

266 Chlorhexidine salts are available in various formulation

267 n rates after the stepwise implementation of chlorhexidine "scrub-the-hub" and daily baths in surgica

268 implemented at different times in the units: chlorhexidine "scrub-the-hub," chlorhexidine daily baths

269 Air polishing with erythritol-chlorhexidine seems to be a viable alternative to the tr

270 while the presence of a specific quantity of chlorhexidine significantly increased fluoride release.

271 uorouracil (RR, 0.34 [95% CI, .14-.82]), and chlorhexidine-silver sulfadiazine (RR, 0.60 [95% CI, .50

272 The second-generation chlorhexidine-silver sulfadiazine catheter is well toler

273 e effect of umbilical cord cleansing with 4% chlorhexidine solution on neonatal mortality and omphali

274 rol) or topical application of 10 mL of a 4% chlorhexidine solution once per day until 3 days after c

275 itted patients received daily bathing with a chlorhexidine solution.

276 he next most highly overexpressed gene under chlorhexidine stress was annotated as encoding a hypothe

277 We describe the selection of reduced chlorhexidine susceptibility during chlorhexidine use in

278 y and that A. polyphaga is more resistant to chlorhexidine than A. castellanii.

279 human pathogen, Acinetobacter baumannii, to chlorhexidine to identify the primary chlorhexidine resi

280 Addition of 2-mg/mL chlorhexidine to the buffer solution resulted in the inh

281 Chlorhexidine umbilical cord washes reduce neonatal mort

282 reduced chlorhexidine susceptibility during chlorhexidine use in a patient with two episodes of cuta

283 a for VAP, form and concentration of topical chlorhexidine used, incidence of VAP, and overall mortal

284 ng semirecumbent positioning, oral care with chlorhexidine, venous thromboembolism prophylaxis, stres

285 lity: 11 of 365 (3.0%) died in the mupirocin/chlorhexidine versus 21 of 301 (7.0%) in the placebo gro

286 ring blood culture contamination rates using chlorhexidine versus iodine tincture for skin antisepsis

287 -related bloodstream infection (CR-BSI) with chlorhexidine versus nonchlorhexidine dressings and cath

288 Aqueous chlorhexidine was associated with a low rate of postinje

289 xin/tobramycin/amphotericin B plus mupirocin/chlorhexidine was associated with the reduction of all-c

290 Subgroup analysis showed that the benefit of chlorhexidine was most marked in cardiac surgery patient

291 Therefore, 0.12% of chlorhexidine was not more effective than placebo.

292 s, 1.89%) compared to procedures after which chlorhexidine was not used as part of post-surgical care

293 Procedures in which chlorhexidine was used during post-surgical care had a l

294 Chlorhexidine was well tolerated, and only 1 patient wit

295 that preoperative MRSA decontamination with chlorhexidine washcloths and oral rinse and intranasal p

296 eo about MRSA decontamination and were given chlorhexidine washcloths and oral rinse and nasal povido

297 ientific, Philadelphia, Pa) and a regimen of chlorhexidine washes were prescribed.

298 kin was prepared with iodine tincture versus chlorhexidine were compared.

299 We compared the effect of chlorhexidine with dry cord care on neonatal mortality r

300 est group (basic periodontal therapy + 0.12% chlorhexidine) with 61 implants; and control group (basi